Abstract
EVIDENCE-BASED ANSWER In patients with type 2 diabetes using insulin, continuous glucose monitoring is associated with glycosylated hemoglobin (HbA1C) reductions of 0.7% over selfmonitoring (SOR: C, meta-analysis with disease-oriented outcomes). In a more diverse population of patients using a variety of management methods for their type 2 diabetes (diet, oral agents, basal insulin), continuous glucose monitoring lowers the HbA1C by 1.3% and selfmonitoring blood glucose lowers the HbA1C by 0.5% (SOR: C, single RCT with disease-oriented outcome).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
